Association of Interleukin 6 gene polymorphisms with genetic susceptibilities to spastic tetraplegia in males: A case-control study

Cytokine

Volumn 61, Issue 3, 2013, Pages 826-830

  Chen, Mingjie ^a,e   Li, Tongchuan ^b   Lin, Sheyu ^a,e   Bi, Dan ^b   Zhu, Dengna ^b   Shang, Qing ^c   Ma, Caiyun ^c   Wang, Honglian ^a,e   Wang, Lei ^a,e   Zhang, Yiting ^a,e   He, Lin ^a,e   Zhu, Changlian ^b,d   Xing, Qinghe ^a,e  

^a FUDAN UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c ZHENGZHOU CHILDREN S HOSPITAL   (China)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Association study; Cerebral palsy; IL6; SNP; Spastic tetraplegia

Indexed keywords

INTERLEUKIN 6;

ADULT; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INTERLEUKIN 6 GENE; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; QUADRIPLEGIA; RISK REDUCTION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SPASTIC TETRAPLEGIA;

ADOLESCENT; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-6; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUADRIPLEGIA; RISK FACTORS;

EID: 84875376004     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.01.011     Document Type: Article

References (44)

1. Rosenbaum P., Paneth N., Leviton A., Goldstein M., Bax M., Damiano D., et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl 2007, 109:8-14.
2. Li S., Lin Q., Liu J. Prevalence of childhood cerebral palsy in six provinces in China. Zhonghua Yi Xue Za Zhi 2001, 81:1220-1223.
3. Day S.M. Do we know what the prevalence of cerebral palsy is?. Dev Med Child Neurol 2011, 53:876-877.
4. Costeff H. Estimated frequency of genetic and nongenetic causes of congenital idiopathic cerebral palsy in west Sweden. Ann Hum Genet 2004, 68:515-520.
5. Lerer I., Sagi M., Meiner V., Cohen T., Zlotogora J., Abeliovich D. Deletion of the ANKRD15 gene at 9p24.3 causes parent-of-origin-dependent inheritance of familial cerebral palsy. Hum Mol Genet 2005, 14:3911-3920.
6. Gibson C.S., MacLennan A.H., Hague W.M., Haan E.A., Priest K., Chan A., et al. Associations between inherited thrombophilias, gestational age, and cerebral palsy. Am J Obstet Gynecol 2005, 193:1437.
7. Zhang T., Wang M., Pan L., Ding W., Wang J.G., Yang L., et al. Study of gene expression profiles and biological mechanism of cerebral palsy using a monozygotic twin pair. Twin Res Hum Genet 2007, 10:496-507.
8. Kuroda M.M., Weck M.E., Sarwark J.F., Hamidullah A., Wainwright M.S. Association of apolipoprotein E genotype and cerebral palsy in children. Pediatrics 2007, 119:306-313.
9. Gibson C.S., Maclennan A.H., Dekker G.A., Goldwater P.N., Sullivan T.R., Munroe D.J., et al. Candidate genes and cerebral palsy: a population-based study. Pediatrics 2008, 122:1079-1085.
10. McMichael G.L., Gibson C.S., Goldwater P.N., Haan E.A., Priest K., Dekker G.A., et al. Association between apolipoprotein E genotype and cerebral palsy is not confirmed in a Caucasian population. Hum Genet 2008, 124:411-416.
11. Clark E.A. Association of candidate gene polymorphisms with death and cerebral palsy following preterm birth. Am J Obstet Gynecol 2009, 201:S263-264.
12. Djukic M., Gibson C.S., Maclennan A.H., Goldwater P.N., Haan E.A., McMichael G., et al. Genetic susceptibility to viral exposure may increase the risk of cerebral palsy. Aust N Z J Obstet Gynaecol 2009, 49:247-253.
13. O'Callaghan M.E., MacLennan A.H., Haan E.A., Dekker G. The genomic basis of cerebral palsy: a HuGE systematic literature review. Hum Genet 2009, 126:149-172.
14. Verkerk A.J., Schot R., Dumee B., Schellekens K., Swagemakers S., Bertoli-Avella A.M., et al. Mutation in the AP4M1 gene provides a model for neuroaxonal injury in cerebral palsy. Am J Hum Genet 2009, 85:40-52.
15. Wu Y.W., Croen L.A., Torres A.R., Van De Water J., Grether J.K., Hsu N.N. Interleukin-6 genotype and risk for cerebral palsy in term and near-term infants. Ann Neurol 2009, 66:663-670.
16. Resch B., Radinger A., Mannhalter C., Horvath B., Binder A., Zenz W., et al. Maternal interleukin-6 (-174) C/C polymorphism is associated with chorioamnionitis and cystic periventricular leucomalacia of the preterm infant. J Perinatol 2010, 30:712-716.
17. Resch B., Muller W.D. Interleukin-6 -174 CC polymorphism is associated with clinical chorioamnionitis and cerebral palsy. Ann Neurol 2010, 68:768-769.
18. Blackman J.A., Apolipoprotein E. Genotype and cerebral palsy. Dev Med Child Neurol 2010, 52:600.
19. Braga L.W., Borigato E.V., Speck-Martins C.E., Imamura E.U., Gorges A.M., Izumi A.P., et al. Apolipoprotein E genotype and cerebral palsy. Dev Med Child Neurol 2010, 52:666-671.
20. Moreno-De-Luca A., Helmers S.L., Mao H., Burns T.G., Melton A.M., Schmidt K.R., et al. Adaptor protein complex-4 (AP-4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability. J Med Genet 2011, 48:141-144.
21. Wu D., Zou Y.F., Xu X.Y., Feng X.L., Yang L., Zhang G.C., et al. The association of genetic polymorphisms with cerebral palsy: a meta-analysis. Dev Med Child Neurol 2011, 53:217-225.
22. Moreno-De-Luca A., Ledbetter D.H., Martin C.L. Genetic insights into the causes and classification of cerebral palsies. Lancet Neurol 2012, 11:283-292.
23. Kapitanovic V.H., Catela I.T., Jokic M., Spaventi R., Kapitanovic S. The association between proinflammatory cytokine polymorphisms and cerebral palsy in very preterm infants. Cytokine 2012, 58:57-64.
24. Terry C.F., Loukaci V., Green F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000, 275:18138-18144.
25. Brull D.J., Montgomery H.E., Sanders J., Dhamrait S., Luong L., Rumley A., et al. Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001, 21:1458-1463.
26. Gu W., Du D.Y., Huang J., Zhang L.Y., Liu Q., Zhu P.F., et al. Identification of interleukin-6 promoter polymorphisms in the Chinese Han population and their functional significance. Crit Care Med 2008, 36:1437-1443.
27. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005, 15:97-98.
28. Li Z., Zhang Z., He Z., Tang W., Li T., Zeng Z., et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res 2009, 19:519-523.
29. Nelson K.B. Causative factors in cerebral palsy. Clin Obstet Gynecol 2008, 51:749-762.
30. Michaud A.P., Bauman N.M., Burke D.K., Manaligod J.M., Smith R.J. Spastic diplegia and other motor disturbances in infants receiving interferon-alpha. Laryngoscope 2004, 114:1231-1236.
31. Dammann O., Leviton A. Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant. Semin Pediatr Neurol 1998, 5:190-201.
32. He M.X., Yang W.L., Zhang M.M., Lian Y.J., Hua H.Y., Zeng J.S., et al. Association between interleukin-6 gene promoter -572C/G polymorphism and the risk of sporadic Alzheimer's disease. Neurol Sci 2010, 31:165-168.
33. Fragoso J.M., Delgadillo H., Juarez-Cedillo T., Rodriguez-Perez J.M., Vallejo M., Perez-Mendez O., et al. The interleukin 6 -572G>C (rs1800796) polymorphism is associated with the risk of developing acute coronary syndrome. Genet Test Mol Biomarkers 2010, 14:759-763.
34. Iwamoto S. Are promoter polymorphisms of interleukin 6 ready to be applied in genetic markers of cardiovascular diseases?. Hypertens Res 2007, 30:575-576.
35. Wang M., Jia J. The interleukin-6 gene -572C/G promoter polymorphism modifies Alzheimer's risk in APOE epsilon 4 carriers. Neurosci Lett 2010, 482:260-263.
36. Ma Y., Tang R.K., Yang X., Peng G.G., Liu Y., Wang X.M., et al. Lack of an association between interleukin-6 gene promoter polymorphisms (-174G/C, -572G/C) and ischemic heart disease and/or ischemic stroke: a meta-analysis. Hum Immunol 2011, 72:641-651.
37. Marx C.E., Jarskog L.F., Lauder J.M., Lieberman J.A., Gilmore J.H. Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia. Biol Psychiatry 2001, 50:743-749.
38. Nelson K.B., Dambrosia J.M., Grether J.K., Phillips T.M. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998, 44:665-675.
39. Yoon B.H., Park C.W., Chaiworapongsa T. Intrauterine infection and the development of cerebral palsy. BJOG 2003, 110(Suppl 20):124-127.
40. Johnston M.V., Hagberg H. Sex and the pathogenesis of cerebral palsy. Dev Med Child Neurol 2007, 49:74-78.
41. Zhu C., Xu F., Wang X., Shibata M., Uchiyama Y., Blomgren K., et al. Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia-ischaemia. J Neurochem 2006, 96:1016-1027.
42. Miller V.M., Lawrence D.A., Coccaro G.A., Mondal T.K., Andrews K., Dreiem A., et al. Sex effects of interleukin-6 deficiency on neuroinflammation in aged C57Bl/6 mice. Brain Res 2010, 1318:11-22.
43. Jarvis S., Glinianaia S.V., Arnaud C., Fauconnier J., Johnson A., McManus V., et al. Case gender and severity in cerebral palsy varies with intrauterine growth. Arch Dis Child 2005, 90:474-479.
44. Chang M.C., Jang S.H., Yoe S.S., Lee E., Kim S., Lee D.G., et al. Diffusion tensor imaging demonstrated radiologic differences between diplegic and quadriplegic cerebral palsy. Neurosci Lett 2012, 512:53-58.